Table 1.
Process | Target |
---|---|
Validation | 15 calendar days |
Scientific assessment | 90 calendar days |
Sponsor response time (quality data) | 180 calendar days |
Sponsor response time (safety and efficacy data) | 180 calendar days |
Expert committee(s) | 60 calendar days |
Authorization procedure | 60 calendar days |
Notification of decision | 7 calendar days |
Overall review time (fast track) | NASs: 250 calendar days |
Overall review time | NASs: No target |
Abbreviations: MCC, Medicines Control Council; NASs, new active substances.